https://andira.ca/andira-pharmaceuticals-welcomes-pioneering-cannabinoid-researcher-and-board-certified-neurologist-ethan-russo-md-to-its-board-of-directors/ 2025-01-08T11:14:39+00:00 https://andira.ca/wp-content/uploads/2025/01/93362186_l_final.jpg https://andira.ca/positive-international-search-report-written-opinion-isr-wo-on-pct-patent-application-antibiotic-cannabinoid-terpene-formulations/ 2025-01-08T11:14:39+00:00 https://andira.ca/wp-content/uploads/2025/01/36405135_l-final.jpg https://andira.ca/andira-pharmaceuticals-secures-exclusive-worldwide-license-for-cannabinoid-antibiotics-and-drug-delivery-systems/ 2025-01-08T11:14:40+00:00 https://andira.ca/wp-content/uploads/2025/01/50772374_1887x701.jpg https://andira.ca/two-mitacs-grants-awarded-for-anti-infective-wound-care-rd/ 2025-01-08T11:14:40+00:00 https://andira.ca/wp-content/uploads/2025/01/72100094_2000x905.jpg https://andira.ca/andira-hires-mcra-to-guide-regulatory-approval-process-for-anti-microbial-wound-care-adhesive/ 2025-01-08T11:14:41+00:00 https://andira.ca/wp-content/uploads/2025/01/Mitacs-Wound-Care-Image.png https://andira.ca/andira-pharmaceuticals-hires-eurofins-discovery-to-further-develop-lead-asset/ 2025-01-08T11:14:41+00:00 https://andira.ca/wp-content/uploads/2025/01/134033869-1024x1024-1.jpg https://andira.ca/life-sciences-review-magazine-features-andira-as-cover-story/ 2025-01-08T11:14:44+00:00 https://andira.ca/wp-content/uploads/2025/01/Life-Sciences-Review-Spread-with-Andira-CEO-Dana-Lambert-1.jpg https://andira.ca/wp-content/uploads/2023/08/2023-8-17-Andira-Life-Science-Review-Cover-236x300.png https://andira.ca/janette-lyons-joins-andira-pharmaceuticals-as-cfo/ 2025-01-09T21:40:05+00:00 https://andira.ca/wp-content/uploads/2025/01/jan-photo.jpg https://andira.ca/wp-content/uploads/2023/02/jan-photo-300x193.jpg https://andira.ca/andira-advances-lead-cannabinoid-compositions-for-metastatic-breast-cancer/ 2025-01-09T21:41:53+00:00 https://andira.ca/wp-content/uploads/2025/01/Metastatic-Cancer-Drug-Development-scaled.jpg https://andira.ca/andira-recognizes-the-outstanding-achievements-of-research-scientist-claudia-helena-dietrich-dds-msc-phd/ 2025-01-09T21:44:03+00:00 https://andira.ca/wp-content/uploads/2025/01/Claudiasphoto-lab-1-e1658936304592.jpeg https://andira.ca/andira-pharmaceuticals-appoints-jonathan-primer-as-lead-commercial-advisor-for-revolutionary-infection-control-technology-matrix3/ 2025-01-09T21:55:49+00:00 https://andira.ca/wp-content/uploads/2025/01/Jonathan-Primer-Headshot.jpg https://andira.ca/wp-content/uploads/2022/05/Jonathan-Primer-headshot-300x179.png https://andira.ca/andira-researcher-dr-claudia-dietrich-wins-best-oral-presentation-at-ubc-plastic-surgery-day-in-talk-about-marix3-antimicrobial-technology/ 2025-01-10T11:54:29+00:00 https://andira.ca/wp-content/uploads/2025/01/111.png https://andira.ca/andira-pharmaceuticals-welcomes-david-s-liu-md-phd-to-advisory-board/ 2025-01-10T20:16:23+00:00 https://andira.ca/wp-content/uploads/2025/01/David-S-Lui-MD-PHD-Advisory-Board-Member.png https://andira.ca/andira-pharmaceuticals-announces-trade-name-change-matrix3-becomes-silvanex/ 2025-01-10T20:18:17+00:00 https://andira.ca/andira-pharmaceuticals-achieves-remarkable-breast-cancer-tumor-regression-with-lead-oncology-candidate-xoxo4/ 2025-01-20T21:36:20+00:00 https://andira.ca/wp-content/uploads/2025/01/XOXO4-Breast-Cancer-Research-Achieves-Extraordinary-Results.jpg https://andira.ca/andira-pharmaceuticals-us-patent-allowed-in-breakthrough-therapeutic-treatment-to-address-deadly-antibiotic-resistant-infections/ 2025-01-20T21:39:02+00:00 https://andira.ca/wp-content/uploads/2025/01/Patented-1-scaled.jpg https://andira.ca/andira-unveils-breakthrough-anti-infective-technology-to-combat-amr-superbugs/ 2025-02-03T19:55:19+00:00 https://andira.ca/wp-content/uploads/2025/02/Andira-Unveils-Breakthrough-Anti-Infective-Technology-to-Combat-AMR-Superbugs.jpg https://andira.ca/andira-pharmaceuticals-announces-completion-of-pre-clinical-safety-studies-advancing-silvanextm-flex-toward-clinical-trials/ 2025-03-19T21:11:38+00:00 https://andira.ca/pre-clinical-success-of-and-259-transdermal-therapy-for-early-stage-breast-cancer/ 2025-06-16T19:15:32+00:00 https://andira.ca/andiras-silvanex-shows-zero-mrsa-resistance-potential-in-landmark-amr-study/ 2025-07-22T17:34:40+00:00 https://andira.ca/andira-pharmaceuticals-advances-first-in-class-topical-therapy-for-post-mastectomy-pain-toward-fda-ind-filing/ 2025-12-07T15:10:40+00:00 https://andira.ca/new-study-reveals-breakthrough-triple-combination-strategy-to-strengthen-silver-based-antimicrobials-against-hospital-infections/ 2026-04-21T13:48:53+00:00